Cerenome, Inc.

CNSY ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $9.6M $12.6M $14.3M $14.6M $15.5M $25.7M $36.9M $52.7M
Accounts Receivable $145.0K $1.2M $1.1M $1.2M $4.2M $3.9M $2.3M $2.1M
Inventory $3.2M $3.7M $4.3M $4.8M $3.7M $3.2M $3.3M $3.4M
Total Current Assets $14.9M $18.7M $21.2M $21.7M $24.6M $34.0M $43.3M $59.0M
Property, Plant & Equipment $3.1M $1.2M $1.6M $1.6M $1.1M $2.2M $1.7M $1.7M
Goodwill $3.9M $3.9M $3.9M $3.9M $3.9M $3.9M $3.9M $3.9M
Intangible Assets (Excl. Goodwill) $7.2M $8.4M $9.0M $9.4M $9.3M $0 $192.0K $413.0K
Total Assets $31.6M $34.6M $37.7M $38.7M $42.1M $43.3M $51.5M $66.3M
Liabilities
Accounts Payable $1.3M $1.3M $1.0M $949.0K $965.0K $1.6M $272.0K $6.8M
Total Current Liabilities $18.4M $12.5M $8.4M $15.9M $14.9M $17.6M $7.8M $13.2M
Long-Term Debt $0 $11.0M $16.7M $18.0M $23.1M $12.9M $22.0M $13.3M
Total Liabilities $18.6M $23.6M $25.5M $44.4M $38.9M $36.8M $41.6M $43.5M
Stockholders' Equity
Retained Earnings $-401.7M $-379.1M $-357.0M $-338.3M $-300.9M $-274.7M $-242.4M $-210.0M
Total Stockholders' Equity $13.0M $11.0M $12.2M $-5.7M $3.1M $6.5M $9.9M $22.9M
← Newer Page 2 of 2 Older →